Clinical trial

Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity

NCT00375089 · University of Florida, Other · Completed

Key facts

NCT number NCT00375089
Title Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
Official title Prader-Willi Syndrome and Early-onset Morbid Obesity Natural History Clinical Protocol
Lead sponsor University of Florida, Other
Collaborators Office of Rare Diseases (ORD) NIH Rare Diseases Clinical Research Network Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Status Completed
Study type Observational
Conditions Prader-Willi Syndrome, Obesity
Intervention type Other
Interventions Group 1, Group 2
Enrollment 392
Start date Sep 1, 2006
Primary completion Jan 1, 2014
Completion Jan 1, 2014
First posted Sep 12, 2006
Last update posted Sep 22, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies